The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Recruiting now

Conditions studied: ST-segment Elevation Myocardial Infarction (STEMI)

In brief

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Key facts

Study ID

NCT06586424

Run by

Universitas Diponegoro

People needed

80

Starts

2024-01-01

Expected to finish

2024-10-05

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

You may not qualify if…

• History of heart failure due to any causes
• Cardiogenic shock before PPCI
• Any infection at the time of presentation
• Pregnant woman
• Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc

Where it is running

• Dr. Kariadi Central General Hospital — Semarang, Central of Java, Indonesia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.